Oncology Medical News about allogeneic hemopoietic SCT

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children
Bone Marrow Transplantation, 10/29/09

Faraci M et al. – Rituximab could be administered in the presence of very high levels of EBV–DNA viral load or in the presence of mid levels of EBV–DNA viral load associated with an increase in the percentage of CD20+ lymphocytes. Through this approach, the authors significantly reduced the number of patients treated with rituximab, and consequently the acute and chronic adverse events related to this treatment.

<< Previous
Components of the metabolic syndrome in 500 adult long-term...

Next >>
Status of minimal residual disease determines outcome of...